Waddell & Reed Financial’s Evogene EVGN Stock Holding History

Waddell & Reed Financial’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-275,722	Closed	-$13M	–	486
2020 Q4	$13M	Hold	275,722	–	–	0.03%	385
2020 Q3	$10.9M	Buy	275,722 +2	+0%	+$36	0.03%	374
2020 Q2	$2.76M	Hold	275,720	–	–	0.01%	433
2020 Q1	$3.23M	Hold	275,720	–	–	0.01%	409
2019 Q4	$4.14M	Sell	275,720 -3,850	-1%	-$57.5K	0.01%	426
2019 Q3	$4.42M	Hold	279,570	–	–	0.01%	424
2019 Q2	$4.25M	Hold	279,570	–	–	0.01%	442
2019 Q1	$4.98M	Buy	279,570 +2	+0%	+$42	0.01%	453
2018 Q4	$5.59M	Hold	279,568	–	–	0.02%	444
2018 Q3	$8.64M	Buy	279,568 +24	+0%	+$694	0.02%	444
2018 Q2	$8M	Hold	279,544	–	–	0.02%	454
2018 Q1	$8.88M	Hold	279,544	–	–	0.02%	436
2017 Q4	$8.58M	Hold	279,544	–	–	0.02%	446
2017 Q3	$12.3M	Hold	279,544	–	–	0.03%	387
2017 Q2	$14.1M	Hold	279,544	–	–	0.03%	383
2017 Q1	$14.9M	Sell	279,544 -26,185	-9%	-$1.36M	0.03%	383
2016 Q4	$15.6M	Sell	305,729 -16,351	-5%	-$936K	0.03%	362
2016 Q3	$20.5M	Hold	322,080	–	–	0.04%	317
2016 Q2	$20.1M	Hold	322,080	–	–	0.04%	307
2016 Q1	$21M	Hold	322,080	–	–	0.04%	300
2015 Q4	$25.9M	Hold	322,080	–	–	0.04%	285
2015 Q3	$26.6M	Hold	322,080	–	–	0.04%	282
2015 Q2	$28.5M	Buy	322,080 +16,107	+5%	+$1.56M	0.04%	288
2015 Q1	$27M	Hold	305,973	–	–	0.04%	303
2014 Q4	$28.2M	Buy	305,973 +773	+0.3%	+$81.9K	0.04%	293
2014 Q3	$40.2M	Buy	305,200 +72,251	+31%	+$9.97M	0.06%	248
2014 Q2	$38M	Buy	232,949 +9,857	+4%	+$1.69M	0.06%	272
2014 Q1	$42.5M	Hold	223,092	–	–	0.06%	248
2013 Q4	$43.8M	Buy	+223,092	New	+$41.2M	0.07%	237

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PDT Partners New York $1.9B AUM 71.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Waddell & Reed Financial's EVGN Position: Q1 2021 in Review

Waddell & Reed Financial sold out of Evogene (EVGN) in Q1 2021, closing a stake of 275,722 shares — an estimated $13M sold.

Waddell & Reed Financial first reported a position in EVGN in Q4 2013 and held it in 29 quarters. The position peaked at $43.8M in Q4 2013. 45 funds tracked by Wall St. Rank hold EVGN as of Q1 2021.

Waddell & Reed Financial reported no remaining Evogene position as of Q1 2021 after selling out during the quarter.
Waddell & Reed Financial sold 275,722 Evogene shares in Q1 2021, an estimated $13M.
Waddell & Reed Financial first reported a position in Evogene in Q4 2013 and held it in 29 quarters.
Waddell & Reed Financial's Evogene position peaked at $43.8M in Q4 2013.
45 funds tracked by Wall St. Rank held Evogene as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.